Vivo Capital VIII, LLC Insider Trading Transactions
Get free email notifications about insider trading for Vivo Capital VIII, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vivo Capital VIII, LLC. Vivo Capital VIII, LLC is 10% Owner in IMPEL NEUROPHARMA INC ($IMPL) and 10% Owner in BioPharmX Corp ($TPND) and 10% Owner in Menlo Therapeutics, Inc. ($MNLO) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Nabriva Therapeutics plc ($NBRV) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
Latest Insider Trading Transactions of Vivo Capital VIII, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALGS, BOLT, CRNX, IMPL, NBRV, TERN, TMBR, MNLO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 713,064 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 5,162,969 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 995,714 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,206,216 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,073,308 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,772,634 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,605,711 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 11,628,174 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 69,380 | 1,040,700 | 349,674 | 280.3 K to 349.7 K (+24.75 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 505,620 | 7,584,300 | 2,535,115 | 2 M to 2.5 M (+24.91 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 13.50 | 12,311 | 166,199 | 280,294 | 268 K to 280.3 K (+4.59 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 13.50 | 89,145 | 1,203,458 | 2,029,495 | 1.9 M to 2 M (+4.59 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 43,550 | 0 | 267,983 | 224.4 K to 268 K (+19.40 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 315,328 | 0 | 1,940,350 | 1.6 M to 1.9 M (+19.40 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 60,813 | 0 | 224,433 | 163.6 K to 224.4 K (+37.17 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 440,119 | 0 | 1,625,022 | 1.2 M to 1.6 M (+37.14 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 65,552 | 0 | 163,620 | 98.1 K to 163.6 K (+66.84 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 474,713 | 0 | 1,184,903 | 710.2 K to 1.2 M (+66.84 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 98,068 | 0 | 98,068 | 0 to 98.1 K |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 710,190 | 0 | 710,190 | 0 to 710.2 K |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | X | 0.07 | 5,655 | 396 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 47,718 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 43,901 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 150,802 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | X | 0.07 | 40,953 | 2,867 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 345,568 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 317,922 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,092,080 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | X | 0.07 | 17,711 | 1,240 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 472,296 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 944,056 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 20.00 | 150,000 | 3,000,000 | 150,000 | 0 to 150 K |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 20.00 | 24,267 | 485,340 | 275,789 | 251.5 K to 275.8 K (+9.65 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 20.00 | 20 | 400 | 251,522 | 251.5 K to 251.5 K (-0.01 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | X | 0.07 | 5,655 | 396 | 251,542 | 245.9 K to 251.5 K (+2.30 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 47,718 | 0 | 245,887 | 198.2 K to 245.9 K (+24.08 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 43,901 | 0 | 198,169 | 154.3 K to 198.2 K (+28.46 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 150,802 | 0 | 154,268 | 3.5 K to 154.3 K (+4,350.89 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 20.00 | 175,733 | 3,514,660 | 1,997,216 | 1.8 M to 2 M (+9.65 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 20.00 | 144 | 2,880 | 1,821,483 | 1.8 M to 1.8 M (-0.01 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | X | 0.07 | 40,953 | 2,867 | 1,821,627 | 1.8 M to 1.8 M (+2.30 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 345,568 | 0 | 1,780,674 | 1.4 M to 1.8 M (+24.08 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 317,922 | 0 | 1,435,106 | 1.1 M to 1.4 M (+28.46 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 1,092,080 | 0 | 1,117,184 | 25.1 K to 1.1 M (+4,350.22 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 20.00 | 62 | 1,240 | 1,448,286 | 1.4 M to 1.4 M (0.00 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | X | 0.07 | 17,711 | 1,240 | 1,448,348 | 1.4 M to 1.4 M (+1.24 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 472,296 | 0 | 1,430,637 | 958.3 K to 1.4 M (+49.28 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 944,056 | 0 | 958,341 | 14.3 K to 958.3 K (+6,608.72 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 50,282 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 364,138 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 98,484 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 713,203 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 357,353 | 6,075,001 | 357,353 | 0 to 357.4 K |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 14,275 | 242,675 | 281,223 | 266.9 K to 281.2 K (+5.35 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 103,372 | 1,757,324 | 2,036,557 | 1.9 M to 2 M (+5.35 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 266,948 | 0 | 266,948 | 0 to 266.9 K |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 1,933,185 | 0 | 1,933,185 | 0 to 1.9 M |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 30,939 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 224,054 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 72,320 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 523,726 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 260,380 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,885,611 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 66,733 | 1,000,995 | 430,372 | 363.6 K to 430.4 K (+18.35 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 483,267 | 7,249,005 | 3,116,658 | 2.6 M to 3.1 M (+18.35 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 30,939 | 0 | 363,639 | 332.7 K to 363.6 K (+9.30 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 72,320 | 0 | 332,700 | 260.4 K to 332.7 K (+27.77 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 260,380 | 0 | 260,380 | 0 to 260.4 K |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 224,054 | 0 | 2,633,391 | 2.4 M to 2.6 M (+9.30 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 523,726 | 0 | 2,409,337 | 1.9 M to 2.4 M (+27.77 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 1,885,611 | 0 | 1,885,611 | 0 to 1.9 M |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.40 | 10,265 | 158,081 | 298,625 | 308.9 K to 298.6 K (-3.32 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.40 | 74,333 | 1,144,728 | 2,162,587 | 2.2 M to 2.2 M (-3.32 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.20 | 3,663 | 55,678 | 308,890 | 312.6 K to 308.9 K (-1.17 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.20 | 26,527 | 403,210 | 2,236,920 | 2.3 M to 2.2 M (-1.17 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.50 | 26,185 | 405,868 | 312,553 | 338.7 K to 312.6 K (-7.73 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.50 | 189,625 | 2,939,188 | 2,263,447 | 2.5 M to 2.3 M (-7.73 %) |
Apr 07 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 14.20 | 742 | 10,536 | 338,738 | 339.5 K to 338.7 K (-0.22 %) |
Apr 07 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 14.20 | 5,373 | 76,297 | 2,453,072 | 2.5 M to 2.5 M (-0.22 %) |
Apr 07 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 13.80 | 36,400 | 502,320 | 339,480 | 375.9 K to 339.5 K (-9.68 %) |
Apr 07 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 13.80 | 263,600 | 3,637,680 | 2,458,445 | 2.7 M to 2.5 M (-9.68 %) |
Mar 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 19.50 | 133 | 2,594 | 168,165 | 168.3 K to 168.2 K (-0.08 %) |
Mar 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 19.50 | 48 | 936 | 375,880 | 375.9 K to 375.9 K (-0.01 %) |
Mar 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 19.50 | 347 | 6,767 | 2,722,045 | 2.7 M to 2.7 M (-0.01 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.40 | 5,904 | 126,346 | 168,298 | 174.2 K to 168.3 K (-3.39 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.40 | 200 | 4,280 | 375,928 | 376.1 K to 375.9 K (-0.05 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.40 | 1,451 | 31,051 | 2,722,392 | 2.7 M to 2.7 M (-0.05 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.00 | 4,614 | 101,508 | 174,202 | 178.8 K to 174.2 K (-2.58 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.00 | 157 | 3,454 | 376,128 | 376.3 K to 376.1 K (-0.04 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.00 | 1,134 | 24,948 | 2,723,843 | 2.7 M to 2.7 M (-0.04 %) |
Feb 06 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.80 | 10,519 | 239,833 | 178,816 | 189.3 K to 178.8 K (-5.56 %) |
Feb 06 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.80 | 357 | 8,140 | 376,285 | 376.6 K to 376.3 K (-0.09 %) |
Feb 06 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.80 | 2,584 | 58,915 | 2,724,977 | 2.7 M to 2.7 M (-0.09 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.70 | 4,220 | 91,574 | 189,335 | 193.6 K to 189.3 K (-2.18 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.70 | 143 | 3,103 | 376,642 | 376.8 K to 376.6 K (-0.04 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.70 | 1,037 | 22,503 | 2,727,561 | 2.7 M to 2.7 M (-0.04 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.10 | 5,940 | 131,274 | 193,555 | 199.5 K to 193.6 K (-2.98 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.10 | 201 | 4,442 | 376,785 | 377 K to 376.8 K (-0.05 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.10 | 1,459 | 32,244 | 2,728,598 | 2.7 M to 2.7 M (-0.05 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.20 | 10,878 | 241,492 | 199,495 | 210.4 K to 199.5 K (-5.17 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.20 | 369 | 8,192 | 376,986 | 377.4 K to 377 K (-0.10 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.20 | 2,673 | 59,341 | 2,730,057 | 2.7 M to 2.7 M (-0.10 %) |
Jun 27 2019 | BPMX | BioPharmX Corp | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 1.02 | 327,870 | 334,427 | 317,270 | 645.1 K to 317.3 K (-50.82 %) |
Mar 25 2019 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.25 | 83,984 | 1,868,644 | 210,373 | 294.4 K to 210.4 K (-28.53 %) |
Mar 25 2019 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.25 | 40,407 | 899,056 | 377,355 | 417.8 K to 377.4 K (-9.67 %) |
Mar 25 2019 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.25 | 292,609 | 6,510,550 | 2,732,730 | 3 M to 2.7 M (-9.67 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 187,648 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,358,903 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,163,311 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 8,424,416 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 20.73 | 153,180 | 3,175,421 | 294,357 | 141.2 K to 294.4 K (+108.50 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 141,177 | 2,400,009 | 141,177 | 0 to 141.2 K |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 7,137 | 121,329 | 417,762 | 410.6 K to 417.8 K (+1.74 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 51,686 | 878,662 | 3,025,339 | 3 M to 3 M (+1.74 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 57,035 | 0 | 410,625 | 353.6 K to 410.6 K (+16.13 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 413,040 | 0 | 2,973,653 | 2.6 M to 3 M (+16.13 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 353,590 | 0 | 353,590 | 0 to 353.6 K |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 2,560,613 | 0 | 2,560,613 | 0 to 2.6 M |
Mar 09 2018 | TPND | BioPharmX Corp | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 0.36 | 2,000,000 | 720,000 | 16,128,515 | 18.1 M to 16.1 M (-11.03 %) |
Jan 31 2018 | TPND | BioPharmX Corp | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,515 | 0 | 0 | |
Jan 31 2018 | TPND | BioPharmX Corp | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 4,328,571 | 0 | 18,128,515 | 13.8 M to 18.1 M (+31.37 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 341,784 | 0 | 0 | |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,475,118 | 0 | 0 | |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 874,817 | 0 | 0 | |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,335,215 | 0 | 0 | |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 126,703 | 0 | 486,695 | 360 K to 486.7 K (+35.20 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 917,559 | 0 | 3,524,541 | 2.6 M to 3.5 M (+35.20 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 324,306 | 0 | 359,992 | 35.7 K to 360 K (+908.78 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 2,348,550 | 0 | 2,606,982 | 258.4 K to 2.6 M (+908.77 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 35,686 | 606,662 | 35,686 | 0 to 35.7 K |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 258,432 | 4,393,344 | 258,432 | 0 to 258.4 K |
Nov 13 2017 | TPND | BioPharmX Corp | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 0.20 | 296,394 | 59,279 | 13,799,944 | 14.1 M to 13.8 M (-2.10 %) |
Sep 18 2017 | NBRV | Nabriva Therapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 9.46 | 6,386 | 60,412 | 494,329 | 487.9 K to 494.3 K (+1.31 %) |
Sep 18 2017 | NBRV | Nabriva Therapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 9.46 | 46,245 | 437,478 | 3,579,861 | 3.5 M to 3.6 M (+1.31 %) |
Page: 1